Saade, Anastasia
Moratelli, Giulia
Dumas, Guillaume
Mabrouki, Asma
Tudesq, Jean-Jacques
Zafrani, Lara
Azoulay, Elie
Darmon, Michael https://orcid.org/0000-0003-4198-8038
Article History
Received: 5 March 2021
Accepted: 10 May 2021
First Online: 25 May 2021
Declarations
:
: This study was approved by an institutional review board (French Intensive Care Society—CE SRLF no. 20-32). Need for informed consent was waived with regard to the study observational design and in accordance with the French law. This study was conducted in accordance with the principles of the Declaration of Helsinki.
: Not applicable.
: MD declares having received grant from MSD, speaker fees from MSD, Astellas and Gilead-Kite and having attended an advisory board for Gilead-Kite. EA has received fees for lectures from Gilead, Pfizer, Baxter and Alexion. His research group was supported by Ablynx, Fisher & Paykel, Jazz Pharma, and MSD. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.